Loading...

Chamie, Karim

Title(s)Associate Professor-in-Residence, Urology
Phone42858
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Quality of care in patients with bladder cancer.
    NIH/NCI F32CA144461Jan 25, 2010 - Jan 24, 2012
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Kunitsky K, Lec PM, Brisbane W, Lenis AT, Chamie K. Sodium Fluorescein for Identification of Intraoperative Urine Leaks During Partial Nephrectomy. Urology. 2020 May 06. PMID: 32387291.
      View in: PubMed
    2. Lenis AT, Golla V, Lec PM, Johnson DC, Faiena I, Lee C, Rahman S, Chamie K. The association between N-methylnaltrexone, a peripherally acting mu-opioid receptor antagonist, and clinical outcomes in patients undergoing robotic-assisted radical cystectomy. World J Urol. 2020 Feb 18. PMID: 32072229.
      View in: PubMed
    3. Pooli A, Salmasi A, Johnson DC, Lenis AT, Faiena I, Lebacle C, Golla V, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K. Positive surgical margins at radical prostatectomy in the United States: Institutional variations and predictive factors. Urol Oncol. 2020 Jan; 38(1):1.e17-1.e23. PMID: 31537483.
      View in: PubMed
    4. Michel J, Goel AN, Golla V, Lenis AT, Johnson DC, Chamie K, Litwin MS. Predicting Short-term Outcomes After Radical Cystectomy Based on Frailty. Urology. 2019 11; 133:25-33. PMID: 31306670.
      View in: PubMed
    5. Lenis AT, Burton CS, Golla V, Pooli A, Faiena I, Johnson DC, Salmasi A, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K. Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma and venous thrombus-Trends and effect on overall survival. Urol Oncol. 2019 Sep; 37(9):577.e9-577.e16. PMID: 30930099.
      View in: PubMed
    6. Donin NM, Kwan L, Lenis AT, Drakaki A, Chamie K. Second primary lung cancer in United States Cancer Survivors, 1992-2008. Cancer Causes Control. 2019 May; 30(5):465-475. PMID: 30900065.
      View in: PubMed
    7. Faiena I, Astrow SH, Elashoff DA, Jain R, Bot A, Chamie K, Belldegrun AS, Pantuck AJ, Drakaki A. Melanoma-associated antigen-A and programmed death-ligand 1 expression are associated with advanced urothelial carcinoma. Cancer Immunol Immunother. 2019 May; 68(5):743-751. PMID: 30790015.
      View in: PubMed
    8. Wang C, Raldow AC, Nickols NG, Nguyen PL, Spratt DE, Dess RT, Yu JB, King CR, Chu FI, Chamie K, Litwin MS, Saigal CS, Reiter RE, Liu ST, Rettig MB, Chang AJ, Steinberg ML, Kupelian PA, Kishan AU. Underutilization of Androgen Deprivation Therapy with External Beam Radiotherapy in Men with High-grade Prostate Cancer. Eur Urol Oncol. 2019 Feb 01. PMID: 31411981.
      View in: PubMed
    9. Leow JJ, Bedke J, Chamie K, Collins JW, Daneshmand S, Grivas P, Heidenreich A, Messing EM, Royce TJ, Sankin AI, Schoenberg MP, Shipley WU, Villers A, Efstathiou JA, Bellmunt J, Stenzl A. SIU-ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer. World J Urol. 2019 Jan; 37(1):61-83. PMID: 30684034.
      View in: PubMed
    10. Golla V, Lenis AT, Faiena I, Chamie K. Intravesical Therapy for Non-muscle Invasive Bladder Cancer-Current and Future Options in the Age of Bacillus Calmette-Guerin Shortage. Rev Urol. 2019; 21(4):145-153. PMID: 32071562.
      View in: PubMed
    11. Salmasi A, Elashoff DA, Guo R, Upfill-Brown A, Rosser CJ, Rose JM, Giffin LC, Gonzalez LE, Chamie K. Urinary Cytokine Profile to Predict Response to Intravesical BCG with or without HS-410 Therapy in Patients with Non-muscle-invasive Bladder Cancer. Cancer Epidemiol Biomarkers Prev. 2019 06; 28(6):1036-1044. PMID: 30593457.
      View in: PubMed
    12. Faiena I, Rosser CJ, Chamie K, Furuya H. Diagnostic biomarkers in non-muscle invasive bladder cancer. World J Urol. 2019 Oct; 37(10):2009-2016. PMID: 30467596.
      View in: PubMed
    13. Pooli A, Salmasi A, Faiena I, Lenis AT, Johnson DC, Lebacle C, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K. Variation in surgical treatment patterns for patients with prostate cancer in the United States: Do patients in academic hospitals fare better? Urol Oncol. 2019 01; 37(1):63-70. PMID: 30446452.
      View in: PubMed
    14. Lenis AT, Asanad K, Blaibel M, Donin NM, Chamie K. Continuous saline bladder irrigation for two hours following transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer does not prevent recurrence or progression compared with intravesical Mitomycin-C. BMC Urol. 2018 Oct 24; 18(1):93. PMID: 30355350.
      View in: PubMed
    15. Upfill-Brown A, Lenis AT, Faiena I, Salmasi AH, Johnson DC, Pooli A, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K. Treatment utilization and overall survival in patients receiving radical nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma: evaluation of updated treatment guidelines. World J Urol. 2019 Jun; 37(6):1157-1164. PMID: 30267197.
      View in: PubMed
    16. Salmasi A, Faiena I, Lenis AT, Pooli A, Johnson DC, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K. Association between renal mass biopsy and upstaging to perinephric fat involvement in a contemporary cohort of patients with clinical T1a renal cell carcinoma. Urol Oncol. 2018 12; 36(12):527.e13-527.e19. PMID: 30228094.
      View in: PubMed
    17. Huo J, Ray-Zack MD, Shan Y, Chamie K, Boorjian SA, Kerr P, Jana B, Freedland SJ, Kamat AM, Mehta HB, Williams SB. Discerning Patterns and Quality of Neoadjuvant Chemotherapy Use Among Patients with Muscle-invasive Bladder Cancer. Eur Urol Oncol. 2019 Sep; 2(5):497-504. PMID: 31411998.
      View in: PubMed
    18. Williams SB, Hudgins HK, Ray-Zack MD, Chamie K, Smaldone MC, Boorjian SA, Daneshmand S, Black PC, Kamat AM, Goebell PJ, Seiler R, Schmitz-Drager B, Nawroth R, Baillargeon J, Klaassen Z, Kulkarni GS, Kim SP, Lee EK, Holzbeierlein JM, Hollenbeck BK, Gore JL. Systematic Review of Factors Associated with the Utilization of Radical Cystectomy for Bladder Cancer. Eur Urol Oncol. 2019 Mar; 2(2):119-125. PMID: 31017086.
      View in: PubMed
    19. Salmasi A, Faiena I, Wu J, Sisk AE, Sachveda A, Vandel JJ, Chamie K, Marks LS, Reiter RE. Radical prostatectomy then and now: Surgical overtreatment of prostate cancer is declining from 2009 to 2016 at a tertiary referral center. Urol Oncol. 2018 09; 36(9):401.e19-401.e25. PMID: 30064933.
      View in: PubMed
    20. Williams SB, Kamat AM, Chamie K, Froehner M, Wirth MP, Wiklund PN, Black PC, Steinberg GD, Boorjian SA, Daneshmand S, Goebell PJ, Pohar KS, Shariat SF, Thalmann GN. Systematic Review of Comorbidity and Competing-risks Assessments for Bladder Cancer Patients. Eur Urol Oncol. 2018 Jun; 1(2):91-100. PMID: 30345422.
      View in: PubMed
    21. Faiena I, Salmasi A, Mendhiratta N, Lenis AT, Pooli A, Drakaki A, Gollapudi K, Blumberg J, Pantuck AJ, Chamie K. Overall survival in patients with residual disease after radical cystectomy and neoadjuvant chemotherapy. World J Urol. 2018 Nov; 36(11):1825-1833. PMID: 29752514.
      View in: PubMed
    22. Faiena I, Cummings AL, Crosetti AM, Pantuck AJ, Chamie K, Drakaki A. Durvalumab: an investigational anti-PD-L1 monoclonal antibody for the treatment of urothelial carcinoma. Drug Des Devel Ther. 2018; 12:209-215. PMID: 29416316.
      View in: PubMed
    23. Bachour K, Faiena I, Salmasi A, Lenis AT, Johnson DC, Pooli A, Drakaki A, Pantuck AJ, Chamie K. Trends in urinary diversion after radical cystectomy for urothelial carcinoma. World J Urol. 2018 Mar; 36(3):409-416. PMID: 29299664.
      View in: PubMed
    24. Lenis AT, Salmasi AH, Donin NM, Faiena I, Johnson DC, Drakaki A, Gollapudi K, Blumberg J, Belldegrun AS, Pantuck AJ, Chamie K. Trends in usage of cytoreductive partial nephrectomy and effect on overall survival in patients with metastatic renal cell carcinoma. Urol Oncol. 2018 02; 36(2):78.e21-78.e28. PMID: 29128421.
      View in: PubMed
    25. Liu ST, Hui G, Mathis C, Chamie K, Pantuck AJ, Drakaki A. The Current Status and Future Role of the Phosphoinositide 3 Kinase/AKT Signaling Pathway in Urothelial Cancer: An Old Pathway in the New Immunotherapy Era. Clin Genitourin Cancer. 2018 04; 16(2):e269-e276. PMID: 29199023.
      View in: PubMed
    26. Faiena I, Salmasi A, Lenis AT, Donin NM, Johnson DC, Bachour K, Drakaki A, Belldegrun AS, Pantuck AJ, Chamie K. Overall survival in patients with metastatic renal cell carcinoma and clinical N1 disease undergoing cytoreductive nephrectomy and lymph node dissection. Urol Oncol. 2018 02; 36(2):79.e19-79.e26. PMID: 29103965.
      View in: PubMed
    27. Lenis AT, Donin NM, Faiena I, Salmasi A, Johnson DC, Drakaki A, Gollapudi K, Blumberg J, Belldegrun A, Pantuck A, Chamie K. Role of surgical approach on lymph node dissection yield and survival in patients with upper tract urothelial carcinoma. Urol Oncol. 2018 01; 36(1):9.e1-9.e9. PMID: 29066013.
      View in: PubMed
    28. Tan HJ, Litwin MS, Chamie K, Saliba D, Hu JC. Trends in Aging-Related Services During Nephrectomy: Implications for Surgery in an Aging Population. J Am Geriatr Soc. 2017 Oct; 65(10):2290-2296. PMID: 28801975.
      View in: PubMed
    29. Packiam VT, Lamm DL, Barocas DA, Trainer A, Fand B, Davis RL, Clark W, Kroeger M, Dumbadze I, Chamie K, Kader AK, Curran D, Gutheil J, Kuan A, Yeung AW, Steinberg GD. An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non-muscle-invasive bladder cancer: Interim results. Urol Oncol. 2018 10; 36(10):440-447. PMID: 28755959.
      View in: PubMed
    30. Huo J, Chu Y, Chamie K, Smaldone MC, Boorjian SA, Baillargeon JG, Kuo YF, Kerr P, O'Malley P, Orihuela E, Tyler DS, Freedland SJ, Giordano SH, Vikram R, Kamat AM, Williams SB. Increased Utilization of Positron Emission Tomography/Computed Tomography (PET/CT) Imaging and Its Economic Impact for Patients Diagnosed With Bladder Cancer. Clin Genitourin Cancer. 2017 Jul 26. PMID: 28826932.
      View in: PubMed
    31. Chamie K, Donin NM, Klöpfer P, Bevan P, Fall B, Wilhelm O, Störkel S, Said J, Gambla M, Hawkins RE, Jankilevich G, Kapoor A, Kopyltsov E, Staehler M, Taari K, Wainstein AJA, Pantuck AJ, Belldegrun AS. Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma: The ARISER Randomized Clinical Trial. JAMA Oncol. 2017 Jul 01; 3(7):913-920. PMID: 27787547.
      View in: PubMed
    32. Williams SB, Huo J, Kosarek CD, Chamie K, Rogers SO, Williams MA, Giordano SH, Kim SP, Kamat AM. Population-based assessment of racial/ethnic differences in utilization of radical cystectomy for patients diagnosed with bladder cancer. Cancer Causes Control. 2017 Jul; 28(7):755-766. PMID: 28477210.
      View in: PubMed
    33. Lenis AT, Donin NM, Johnson DC, Faiena I, Salmasi A, Drakaki A, Belldegrun A, Pantuck A, Chamie K. Adjuvant Therapy for High Risk Localized Kidney Cancer: Emerging Evidence and Future Clinical Trials. J Urol. 2018 01; 199(1):43-52. PMID: 28479237.
      View in: PubMed
    34. Lenis AT, Asanad K, Blaibel M, Donin NM, Chamie K. Association between Metabolic Syndrome and Recurrence of Nonmuscle Invasive Bladder Cancer following bacillus Calmette-Guérin Treatment. Urol Pract. 2018 Mar; 5(2):132-138. PMID: 29577063.
      View in: PubMed
    35. Williams SB, Huo J, Chamie K, Smaldone MC, Kosarek CD, Fang JE, Ynalvez LA, Kim SP, Hoffman KE, Giordano SH, Chapin BF. Discerning the survival advantage among patients with prostate cancer who undergo radical prostatectomy or radiotherapy: The limitations of cancer registry data. Cancer. 2017 05 01; 123(9):1617-1624. PMID: 28099688.
      View in: PubMed
    36. Donin NM, Strauss-Ayali D, Agmon-Gerstein Y, Malchi N, Lenis AT, Holden S, Pantuck AJ, Belldegrun AS, Chamie K. Serial retrograde instillations of sustained release formulation of mitomycin C to the upper urinary tract of the Yorkshire swine using a thermosensitive polymer: Safety and feasibility. Urol Oncol. 2017 05; 35(5):272-278. PMID: 28065395.
      View in: PubMed
    37. Miller ET, Chamie K, Kwan L, Lewis MS, Knudsen BS, Garraway IP. Impact of treatment on progression to castration-resistance, metastases, and death in men with localized high-grade prostate cancer. Cancer Med. 2017 01; 6(1):163-172. PMID: 27997745.
      View in: PubMed
    38. Tan HJ, Shirk JD, Chamie K, Litwin MS, Hu JC. Patient Function and the Value of Surgical Care for Kidney Cancer. J Urol. 2017 05; 197(5):1200-1207. PMID: 27986531.
      View in: PubMed
    39. Zimmermann M, Wang SS, Zhang H, Lin TY, Malfatti M, Haack K, Ognibene T, Yang H, Airhart S, Turteltaub KW, Cimino GD, Tepper CG, Drakaki A, Chamie K, de Vere White R, Pan CX, Henderson PT. Microdose-Induced Drug-DNA Adducts as Biomarkers of Chemotherapy Resistance in Humans and Mice. Mol Cancer Ther. 2017 02; 16(2):376-387. PMID: 27903751.
      View in: PubMed
    40. Lenis AT, Chamie K. Regionalization of Cystectomy: Importance of Care Coordination, Bundled Payments and Surgical Ownership. J Urol. 2017 02; 197(2):278-279. PMID: 27845149.
      View in: PubMed
    41. Donin NM, Chamie K, Lenis AT, Pantuck AJ, Reddy M, Kivlin D, Holldack J, Pozzi R, Hakim G, Karsh LI, Lamm DL, Belkoff LH, Belldegrun AS, Holden S, Shore N. A phase 2 study of TMX-101, intravesical imiquimod, for the treatment of carcinoma in situ bladder cancer. Urol Oncol. 2017 02; 35(2):39.e1-39.e7. PMID: 28341495.
      View in: PubMed
    42. Donin NM, Duarte S, Lenis AT, Caliliw R, Torres C, Smithson A, Strauss-Ayali D, Agmon-Gerstein Y, Malchi N, Said J, Raman SS, Holden S, Pantuck A, Belldegrun AS, Chamie K. Sustained-release Formulation of Mitomycin C to the Upper Urinary Tract Using a Thermosensitive Polymer: A Preclinical Study. Urology. 2017 Jan; 99:270-277. PMID: 27720772.
      View in: PubMed
    43. Williams SB, Duan Z, Chamie K, Hoffman KE, Smith BD, Hu JC, Shah JB, Davis JW, Giordano SH. Risk of hospitalisation after primary treatment for prostate cancer. BJU Int. 2017 07; 120(1):48-55. PMID: 27561186.
      View in: PubMed
    44. Krishna S, Fan Y, Jarosek S, Adejoro O, Chamie K, Konety B. Racial Disparities in Active Surveillance for Prostate Cancer. J Urol. 2017 02; 197(2):342-349. PMID: 27596691.
      View in: PubMed
    45. Tan HJ, Chamie K, Daskivich TJ, Litwin MS, Hu JC. Patient function, long-term survival, and use of surgery in patients with kidney cancer. Cancer. 2016 Dec 15; 122(24):3776-3784. PMID: 27518165.
      View in: PubMed
    46. Donin NM, Lenis AT, Holden S, Drakaki A, Pantuck A, Belldegrun A, Chamie K. Immunotherapy for the Treatment of Urothelial Carcinoma. J Urol. 2017 01; 197(1):14-22. PMID: 27460757.
      View in: PubMed
    47. Donin NM, Pantuck A, Klöpfer P, Bevan P, Fall B, Said J, Belldegrun AS, Chamie K. Body Mass Index and Survival in a Prospective Randomized Trial of Localized High-Risk Renal Cell Carcinoma. Cancer Epidemiol Biomarkers Prev. 2016 09; 25(9):1326-32. PMID: 27418270.
      View in: PubMed
    48. Donin N, Filson C, Drakaki A, Tan HJ, Castillo A, Kwan L, Litwin M, Chamie K. Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008. Cancer. 2016 10; 122(19):3075-86. PMID: 27377470.
      View in: PubMed
    49. Filson CP, Tan HJ, Chamie K, Laviana AA, Hu JC. Determinants of radical cystectomy operative time. Urol Oncol. 2016 10; 34(10):431.e17-24. PMID: 27372282.
      View in: PubMed
    50. Lenis AT, Donin NM, Litwin MS, Saigal CS, Lai J, Hanley JM, Konety BR, Chamie K. Association Between Number of Endoscopic Resections and Utilization of Bacillus Calmette-Guérin Therapy for Patients With High-Grade, Non-Muscle-Invasive Bladder Cancer. Clin Genitourin Cancer. 2017 02; 15(1):e25-e31. PMID: 27432529.
      View in: PubMed
    51. Williams SB, Huo J, Chamie K, Hu JC, Giordano SH, Hoffman KE, Dinney CPN, Kamat AM, Shih YT. Underutilization of Radical Cystectomy Among Patients Diagnosed with Clinical Stage T2 Muscle-invasive Bladder Cancer. Eur Urol Focus. 2017 04; 3(2-3):258-264. PMID: 28753760.
      View in: PubMed
    52. Chamie K, Williams SB, Hershman DL, Wright JD, Nguyen PL, Hu JC. Population-based assessment of determining predictors for quality of prostate cancer surveillance. Cancer. 2015 Dec 01; 121(23):4150-7. PMID: 26307939.
      View in: PubMed
    53. Williams SB, Chamie K, Hu JC. Watchful Waiting-Active Surveillance in Low-Risk Prostate Cancer-Reply. JAMA Oncol. 2015 Aug; 1(5):689-90. PMID: 26181144.
      View in: PubMed
    54. Chamie K, Williams SB, Hu JC. Population-Based Assessment of Determining Treatments for Prostate Cancer. JAMA Oncol. 2015 Apr; 1(1):60-7. PMID: 26182305.
      View in: PubMed
    55. Chamie K, Klöpfer P, Bevan P, Störkel S, Said J, Fall B, Belldegrun AS, Pantuck AJ. Carbonic anhydrase-IX score is a novel biomarker that predicts recurrence and survival for high-risk, nonmetastatic renal cell carcinoma: Data from the phase III ARISER clinical trial. Urol Oncol. 2015 May; 33(5):204.e25-33. PMID: 25823535.
      View in: PubMed
    56. Lenis AT, Chamie K. Bladder cancer in 2014: From the genomic frontier to immunotherapeutics. Nat Rev Urol. 2015 Feb; 12(2):74-6. PMID: 25558841.
      View in: PubMed
    57. Chamie K, Ballon-Landa E, Daskivich TJ, Bassett JC, Lai J, Hanley JM, Konety BR, Litwin MS, Saigal CS. Treatment and survival in patients with recurrent high-risk non-muscle-invasive bladder cancer. Urol Oncol. 2015 Jan; 33(1):20.e9-20.e17. PMID: 25443267.
      View in: PubMed
    58. Chamie K, Ballon-Landa E, Bassett JC, Daskivich TJ, Leventhal M, Deapen D, Litwin MS. Quality of diagnostic staging in patients with bladder cancer: a process-outcomes link. Cancer. 2015 Feb 01; 121(3):379-85. PMID: 25339141.
      View in: PubMed
    59. Kaplan AL, Agarwal N, Setlur NP, Tan HJ, Niedzwiecki D, McLaughlin N, Burke MA, Steinberg K, Chamie K, Saigal CS. Measuring the cost of care in benign prostatic hyperplasia using time-driven activity-based costing (TDABC). Healthc (Amst). 2015 Mar; 3(1):43-8. PMID: 26179588.
      View in: PubMed
    60. Hu JC, Williams SB, Carter SC, Eggener SE, Prasad S, Chamie K, Trinh QD, Sun M, Nguyen PL, Lipsitz SR. Population-based assessment of prostate-specific antigen testing for prostate cancer in the elderly. Urol Oncol. 2015 Feb; 33(2):69.e29-34. PMID: 25017694.
      View in: PubMed
    61. Hu JC, Gandaglia G, Karakiewicz PI, Nguyen PL, Trinh QD, Shih YC, Abdollah F, Chamie K, Wright JL, Ganz PA, Sun M. Comparative effectiveness of robot-assisted versus open radical prostatectomy cancer control. Eur Urol. 2014 Oct; 66(4):666-72. PMID: 24602934.
      View in: PubMed
    62. Chamie K, Sonn GA, Finley DS, Tan N, Margolis DJ, Raman SS, Natarajan S, Huang J, Reiter RE. The role of magnetic resonance imaging in delineating clinically significant prostate cancer. Urology. 2014 Feb; 83(2):369-75. PMID: 24468511.
      View in: PubMed
    63. Bergman J, Neuhausen K, Chamie K, Scales CD, Carter S, Kwan L, Lerman SE, Aronson W, Litwin MS. Building a medical neighborhood in the safety net: an innovative technology improves hematuria workups. Urology. 2013 Dec; 82(6):1277-82. PMID: 24103564.
      View in: PubMed
    64. Kaplan AL, Litwin MS, Chamie K. The future of bladder cancer care in the USA. Nat Rev Urol. 2014 Jan; 11(1):59-62. PMID: 23979659.
      View in: PubMed
    65. Daskivich TJ, Chamie K, Kwan L, Dash A, Greenfield S, Litwin MS. Matching tumor risk with aggressiveness of treatment in men with multiple comorbidities and early-stage prostate cancer. Cancer. 2013 Oct 01; 119(19):3446-53. PMID: 23861016.
      View in: PubMed
    66. Chamie K, Litwin MS, Bassett JC, Daskivich TJ, Lai J, Hanley JM, Konety BR, Saigal CS. Recurrence of high-risk bladder cancer: a population-based analysis. Cancer. 2013 Sep 01; 119(17):3219-27. PMID: 23737352.
      View in: PubMed
    67. Chamie K, Oberfoell S, Kwan L, Labo J, Wei JT, Litwin MS. Body mass index and prostate cancer severity: do obese men harbor more aggressive disease on prostate biopsy? Urology. 2013 May; 81(5):949-55. PMID: 23477756.
      View in: PubMed
    68. Kroeger N, Klatte T, Chamie K, Rao PN, Birkhäuser FD, Sonn GA, Riss J, Kabbinavar FF, Belldegrun AS, Pantuck AJ. Deletions of chromosomes 3p and 14q molecularly subclassify clear cell renal cell carcinoma. Cancer. 2013 Apr 15; 119(8):1547-54. PMID: 23335244.
      View in: PubMed
    69. Chamie K. Editorial comment. J Urol. 2013 Jan; 189(1):65. PMID: 23164378.
      View in: PubMed
    70. Keegan KA, Schupp CW, Chamie K, Hellenthal NJ, Evans CP, Koppie TM. Histopathology of surgically treated renal cell carcinoma: survival differences by subtype and stage. J Urol. 2012 Aug; 188(2):391-7. PMID: 22698625.
      View in: PubMed
    71. Bassett JC, Gore JL, Chi AC, Kwan L, McCarthy W, Chamie K, Saigal CS. Impact of a bladder cancer diagnosis on smoking behavior. J Clin Oncol. 2012 May 20; 30(15):1871-8. PMID: 22529264.
      View in: PubMed
    72. Logan JE, Rampersaud EN, Sonn GA, Chamie K, Belldegrun AS, Pantuck AJ, Slamon DJ, Kabbinavar FF. Systemic therapy for metastatic renal cell carcinoma: a review and update. Rev Urol. 2012; 14(3-4):65-78. PMID: 23526579.
      View in: PubMed
    73. Chamie K, Litwin MS. Quality of bladder cancer care in the USA. Expert Rev Pharmacoecon Outcomes Res. 2011 Dec; 11(6):619-21. PMID: 22098276.
      View in: PubMed
    74. Chamie K, Connor SE, Maliski SL, Fink A, Kwan L, Litwin MS. Prostate cancer survivorship: lessons from caring for the uninsured. Urol Oncol. 2012 Jan-Feb; 30(1):102-8. PMID: 22127017.
      View in: PubMed
    75. Heckman JE, Chamie K, Maliski SL, Fink A, Kwan L, Connor SE, Litwin MS. The role of self-efficacy in quality of life for disadvantaged men with prostate cancer. J Urol. 2011 Nov; 186(5):1855-61. PMID: 21944084.
      View in: PubMed
    76. Daskivich TJ, Chamie K, Kwan L, Labo J, Dash A, Greenfield S, Litwin MS. Improved prediction of long-term, other cause mortality in men with prostate cancer. J Urol. 2011 Nov; 186(5):1868-73. PMID: 21944092.
      View in: PubMed
    77. Chamie K, Daskivich TJ, Kwan L, Labo J, Dash A, Greenfield S, Litwin MS. Comorbidities, treatment and ensuing survival in men with prostate cancer. J Gen Intern Med. 2012 May; 27(5):492-9. PMID: 21935751.
      View in: PubMed
    78. Wu JN, Craig J, Chamie K, Asplin J, Ali MR, Low RK. Urolithiasis risk factors in the bariatric population undergoing gastric bypass surgery. Surg Obes Relat Dis. 2013 Jan-Feb; 9(1):83-7. PMID: 22100051.
      View in: PubMed
    79. Chamie K, Kwan L, Connor SE, Zavala M, Labo J, Litwin MS. The impact of social networks and partnership status on treatment choice in men with localized prostate cancer. BJU Int. 2012 Apr; 109(7):1006-12. PMID: 21895934.
      View in: PubMed
    80. Chamie K, Saigal CS, Lai J, Hanley JM, Setodji CM, Konety BR, Litwin MS. Quality of care in patients with bladder cancer: a case report? Cancer. 2012 Mar 01; 118(5):1412-21. PMID: 21823107.
      View in: PubMed
    81. Chamie K, Saigal CS, Lai J, Hanley JM, Setodji CM, Konety BR, Litwin MS. Compliance with guidelines for patients with bladder cancer: variation in the delivery of care. Cancer. 2011 Dec 01; 117(23):5392-401. PMID: 21780079.
      View in: PubMed
    82. Yap SA, Schupp CW, Chamie K, Evans CP, Koppie TM. Effect of age on transitional cell carcinoma of the upper urinary tract: presentation, treatment, and outcomes. Urology. 2011 Jul; 78(1):87-92. PMID: 21601253.
      View in: PubMed
    83. Chamie K, Saigal CS, Litwin MS. Patients and solipsism: the psychology of decision making for prostate cancer treatment. Urol Oncol. 2011 May-Jun; 29(3):233-4. PMID: 21714161.
      View in: PubMed
    84. Nguyen HG, Chamie K, Nguyen KG, Durbin-Johnson B, Kurzrock EA. Outcomes after pediatric ureteral reimplantation: a population based analysis. J Urol. 2011 Jun; 185(6):2292-7. PMID: 21511291.
      View in: PubMed
    85. Palvolgyi R, Daskivich TJ, Chamie K, Kwan L, Litwin MS. Bone scan overuse in staging of prostate cancer: an analysis of a Veterans Affairs cohort. Urology. 2011 Jun; 77(6):1330-6. PMID: 21492911.
      View in: PubMed
    86. Daskivich TJ, Chamie K, Kwan L, Labo J, Dash A, Greenfield S, Litwin MS. Comorbidity and competing risks for mortality in men with prostate cancer. Cancer. 2011 Oct 15; 117(20):4642-50. PMID: 21480201.
      View in: PubMed
    87. Chamie K, Kurzrock EA, Evans CP, Litwin MS, Koppie TM, Wootton-Gorges SL, Boone JM, Lara PN, Devere White RW. Secondary malignancies among nonseminomatous germ cell tumor cancer survivors. Cancer. 2011 Sep 15; 117(18):4219-30. PMID: 21412759.
      View in: PubMed
    88. Chamie K, Sadetsky N, Litwin MS. Physician assessment of pretreatment functional status: a process-outcomes link. J Urol. 2011 Apr; 185(4):1229-33. PMID: 21334026.
      View in: PubMed
    89. Daskivich TJ, Chamie K, Kwan L, Labo J, Palvolgyi R, Dash A, Greenfield S, Litwin MS. Overtreatment of men with low-risk prostate cancer and significant comorbidity. Cancer. 2011 May 15; 117(10):2058-66. PMID: 21523717.
      View in: PubMed
    90. Chamie K, Litwin MS. Prostate cancer: the challenge of comparing open and laparoscopic surgery. Nat Rev Urol. 2010 Mar; 7(3):121-2. PMID: 20220751.
      View in: PubMed
    91. Chamie K, Chi A, Hu B, Keegan KA, Kurzrock EA. Contemporary open ureteral reimplantation without morphine: assessment of pain and outcomes. J Urol. 2009 Sep; 182(3):1147-51. PMID: 19625056.
      View in: PubMed
    92. Bedolla RG, Wang Y, Asuncion A, Chamie K, Siddiqui S, Mudryj MM, Prihoda TJ, Siddiqui J, Chinnaiyan AM, Mehra R, de Vere White RW, Ghosh PM. Nuclear versus cytoplasmic localization of filamin A in prostate cancer: immunohistochemical correlation with metastases. Clin Cancer Res. 2009 Feb 01; 15(3):788-96. PMID: 19188148.
      View in: PubMed
    93. Hellenthal NJ, Chamie K, Ramirez ML, deVere White RW. Sociodemographic factors associated with nephrectomy in patients with metastatic renal cell carcinoma. J Urol. 2009 Mar; 181(3):1013-8; discussion 1018-9. PMID: 19150554.
      View in: PubMed
    94. Chamie K, DeVere White RW, Lee D, Ok JH, Ellison LM. Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer. Cancer. 2008 Nov 01; 113(9):2464-70. PMID: 18666213.
      View in: PubMed
    95. Chamie K, Ghosh PM, Koppie TM, Romero V, Troppmann C, deVere White RW. The effect of sirolimus on prostate-specific antigen (PSA) levels in male renal transplant recipients without prostate cancer. Am J Transplant. 2008 Dec; 8(12):2668-73. PMID: 18853950.
      View in: PubMed
    96. Chamie K, Hu B, Devere White RW, Ellison LM. Cystectomy in the elderly: does the survival benefit in younger patients translate to the octogenarians? BJU Int. 2008 Aug; 102(3):284-90. PMID: 18410437.
      View in: PubMed
    97. Chamie K, Tanaka ST, Hu B, Kurzrock EA. Short stay pyeloplasty: variables affecting pain and length of stay. J Urol. 2008 Apr; 179(4):1549-52. PMID: 18295264.
      View in: PubMed
    98. Cambio AJ, Ellison LM, Chamie K, deVere White RW, Evans CP. Cost-benefit and outcome analysis: effect of prostate biopsy undergrading. Urology. 2007 Jun; 69(6):1152-6. PMID: 17572205.
      View in: PubMed
    99. Daneshmand S, Youssefzadeh D, Chamie K, Boswell W, Wu N, Stein JP, Boyd S, Skinner DG. Benign retroperitoneal schwannoma: a case series and review of the literature. Urology. 2003 Dec; 62(6):993-7. PMID: 14665342.
      View in: PubMed
    100. Perfetti R, Hui H, Chamie K, Binder S, Seibert M, McLenithan J, Silver K, Walston JD. Pancreatic beta-cells expressing the Arg64 variant of the beta(3)-adrenergic receptor exhibit abnormal insulin secretory activity. J Mol Endocrinol. 2001 Oct; 27(2):133-44. PMID: 11564599.
      View in: PubMed
    101. Perfetti R, Chamie K. Enhancing insulin action: from chemical elements to thiazolidinediones. J Endocrinol Invest. 2001 Apr; 24(4):274-87. PMID: 11383915.
      View in: PubMed